MEBO International Group
Since its formal establishment in 1987, MEBO has developed
scientifically revolutionary medicines and nutrients
that have been used successfully to treat millions of patients. In
addition to China, MEBO products have been introduced to more than
20 countries, including Singapore, South Korea, the Philippines,
Thailand, Malaysia and most of the Middle Eastern countries
including United Arab Emirates, Egypt, Saudi Arabia and Kuwait.
They are currently being developed for the U.S. market.
SKIN REGENERATION FOR BURNS AND WOUNDS
MEBO?s achievements in the regeneration of human organs began in
1987 with the physiological repair and regeneration of extensively
wounded skin, the largest organ of the body, by using a proprietary
product called moist-exposed burn ointment (MEBO) from
which the company?s name is originated. The MEBO wound
ointment, used in conjunction with the techniques of Moist-Exposed
Burn Treatment (MEBT), have benefited millions”healing acute or
chronic wounds restoring the physiological structure and
function of the skin, and dramatically reducing morbidity and
mortality of burn patients.
REGENERATION BEYOND THE SKIN
MEBO?s medicines and nutrients are combinations of essential
natural substances processed through and formulated with our
proprietary technologies. Moving beyond a well-established clinical
and scientific foundation based in burn treatment, acute and
chronic wound healing, and the repair and regeneration of the
gastrointestinal tract lining, MEBO is now exploring new medicines
and nutrients using MEBO?s groundbreaking regenerative
MEBO?s mission is to continue to harness the natural power of the
human body to regenerate or heal itself by developing additional
MEBO regenerative medicines and nutrients that will significantly
impact human health.